Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Atherosclerosis. 2012 Nov 28;226(2):483–489. doi: 10.1016/j.atherosclerosis.2012.11.020

Table 1.

Adiponectin and combined vascular events (Hazard Ratio, 95% Confidence Interval), N=692 events (overall N=2900)

Adiponectin Model 1 Model 2 Model 3 Model 4 Model 5
Continuous 1.04 (1.03–1.05) 1.00 (0.99–1.02) 1.03 (1.01–1.04) 1.03 (1.01–1.05) 1.02 (1.01–1.03)
Quartile 1 0.63 (0.51–0.77) 1.05 (0.84–1.31) 0.73 (0.57–0.94) 0.64 (0.47–0.87) 0.83 (0.67–1.03)
Quartile 2 0.50 (0.41–0.62) 0.82 (0.65–1.03) 0.61 (0.47–0.79) 0.49 (0.44–0.80) 0.69 (0.54–0.87)
Quartile 3 0.66 (0.54–0.81) 0.88 (0.71–1.07) 0.73 (0.58–0.91) 0.75 (0.58–0.98) 0.75 (0.60–0.93)
Quartile 4 ref ref ref ref ref

Model 1: Univariate

Model 2: Adjusting for age, sex, race/ethnicity

Model 3: Adjusting for age, sex, race/ethnicity, smoking, hypertension, diabetes, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglycerides, waist circumference, moderate alcohol use, moderate-heavy physical activity, previous cardiac disease history

Model 4: Adjusting for the variables in model 3 + hsCRP (N=2091)

Model 5: Adjusting for the NOMAS global vascular risk score